ADMA Biologics, Inc. is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases. The company's mission is to improve the lives of immunocompromised patients by providing high-quality, FDA-approved immune globulin products. ADMA operates through a vertically integrated manufacturing process, ensuring control over the production of its specialty biologic products.